REFERENCES
- Pellicer A. Frequency of thalassemia in a sample of the Spanish population. Am J Hum Genet. 1967; 19(6)695–699
- Pellicer A. Frecuencia de talasemia en naturales de las provincias de Jaén y Toledo. Rev Diagn Biol. 1967; 16(1)331–336
- Pellicer A. Studies on thalassemia, glucose-6-phosphate dehydrogenase deficiency, and sickle cell trait in the Province of Huelva (Spain). Am J Hum Genet. 1969; 21(2)109–114
- Pellicer A, Casado A. Frequency of thalassemia and G6PD deficiency in five provinces of Spain. Am J Hum Genet. 1970; 22(3)298–303
- Marco P, Merino J, Calatayud R. Incidencia de la beta talasemia heterocigota en la provincia de Alicante. Sangre (Barc). 1986; 31(1)247–252
- Baiget M. Thalassemic syndromes in Spain. Preliminarly epidemiologic data. Study Group for Hemoglobinopathies and Thalassemias. Sangre (Barc). 1986; 31(5)609–613
- García Arias MB, Cantalejo López MA, Cela de Julián ME, Bravo Clouzet R, Galarón García P, Beléndez Bieler C. Sickle cell disease: Registry of the Spanish Society of Pediatric Hematology. An Pediatr (Barc). 2006; 64(1)78–84
- Kazazian HH, Jr, Boehm CD. Molecular basis and prenatal diagnosis of β-thalassemia. Blood. 1988; 72(4)1107–1116
- Kattamis C, Kattamis AC. Genotypes and phenotypes of β-thalassemia in Mediterranean populations. Pediatr Hematol Oncol. 1997; 14(3)vii–ix
- Cao A, Saba L, Galanello R, Rosatelli MC. Molecular diagnosis and carrier screening for β thalassemia. JAMA. 1997; 278(15)1273–1277
- Ribeiro ML, Gonçalves P, Cunha E, et al. Genetic heterogeneity of β-thalassemia in populations of the Iberian Peninsula. Hemoglobin. 1997; 21(3)261–269
- Moreno Miralles I, Bolufer Gilabert P, Pérez Sirvent M. Alteraciones moleculares de las talasemias en España. Revisión de los estudios existentes. Med Clin (Barc). 1999; 113(20)789–794
- http://www.ine.es/inebmenu/mnu_cifraspob.htm, National Institute of Statistics. Instituto Nacional de Estadistica (INE)
- Gustincich S, Manfioletti G, Del Sal G, Schneider C, Carninci P. A fast method for high-quality genomic DNA extraction from whole human blood. BioTechniques. 1991; 11(3)298–302
- Mañú Pereira Mdel M, Cabot A, Martínez González A, et al. Neonatal screening of hemoglobinopathies and G6PD deficiency in Catalonia (Spain). Molecular study of sickle cell disease associated with α thalassemia and G6PD deficiency. Med Clin (Barc). 2007; 129(5)161–164
- Old JM. Screening and genetic diagnosis of haemoglobin disorders. Blood Rev. 2003; 17(1)43–53
- Amselem S, Nunes V, Vidaud M, et al. Determination of the spectrum of β thalassemia in Spain by use of dot-blot analysis of amplified β globin DNA. Am J Hum Genet. 1988; 43(1)95–100
- Villegas A, Ropero P, González FA, Anguita E, Espinós D. The thalassemia syndromes: Molecular characterization in the Spanish population. Hemoglobin. 2001; 25(3)273–283
- Ropero P, Villegas A, Martí E, González FA. The first case of β-thalassemia by frameshift CD5 (−CT) mutation in Spain. Med Clin (Barc). 1999; 112(14)556–557
- Roberts I, Montalembert M. Sickle cell disease as a paradigm of immigration hematology: New challenges for hematologists in Europe. Haematologica. 2007; 92(7)865–871
- Dulín Iñígueza E, Cantalejo López MA, Cela de Julián ME, et al. Detección precoz neonatal de anemia falciforme y otras hemoglobinopatías en la Comunidad Autónoma de Madrid. Estudio piloto. An Pediatr (Barc). 2003; 58(2)146–155
- Calvo-Villas JM, Zapata Ramos MF, Cuesta Tovar J, et al. Prevalence of hemoglobinopathies in pregnant women in the Lanzarote health sanitary area. An Med Interna. 2006; 23(5)206–212